Jan 2 (Reuters) - Drug distributor Cencora COR.N raised its annual adjusted profit forecast on Thursday.
Excluding one-off items, the company now sees its 2024 profit to be between $15.15 and $15.45 per share, compared with its previous range of $14.80 to $15.10 per share.
(Reporting by Puyaan Singh in Bengaluru; Editing by Mohammed Safi Shamsi)
((Puyaan.Singh@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.